Screener
Cullinan Therapeutics, Inc. CGEM Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
FAQ
- What is Cullinan Therapeutics, Inc.'s enterprise value?
- Cullinan Therapeutics, Inc. (CGEM) reported enterprise value of $1.04B in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s enterprise value changed year-over-year?
- Cullinan Therapeutics, Inc.'s enterprise value increased by 166.4% year-over-year, from $391.37M to $1.04B.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s enterprise value has grown at a -4.3% compound annual growth rate (CAGR), from $627.18M to $525.79M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Cullinan Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude